Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Steven De Vleeschouwer, Guido Wilms et al.|Cancer Immunology Immunotherapy|2012Cited by 162
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot studyHilko Ardon, Steven De Vleeschouwer, Stefaan Van Gool et al.|Journal of Neuro-Oncology|2010Cited by 146
Defining pseudoprogression in glioblastoma multiformeElke Van Mieghem, Paul M. Clément, Agnieszka Woźniak et al.|European Journal of Neurology|2013Cited by 55
Pediatric Inflammatory DiseasesMichele Gallucci, C. Micheli, Justin D. Smith et al.|The Neuroradiology Journal|2012Cited by 9
Neurocysticercosis: a poorly understood disease.M Vantomme, Wim Robberecht, R Swartenbroekx et al.|PubMed|1995Cited by 4